Live feed07:00:00·989dPRReleasevia QuantisnowFreeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher DiseaseByQuantisnow·Wall Street's wire, on your screen.FRLN· Freeline Therapeutics Holdings plcHealth Care
